TSX: ACB
EDMONTON, Feb. 14, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced
that the Company has signed a Letter of Intent ("LOI") with the
Société des Alcools du Québec ("SAQ") to supply a minimum of 5,000
kg of cannabis per annum for the Quebec adult consumer market, once
legalized.
Under the terms of the LOI, Aurora will supply the Quebec market, on a monthly basis, with a wide
variety of premium product from its facilities in Quebec, and elsewhere if demand requires.
Supply quantities will be determined based on demand on a month by
month basis, with a minimum of 5,000 for the first year, but no set
maximum.
"This LOI is significant in terms of product volume, and an
important step in our commercial development," said Terry Booth, CEO of Aurora. "It also reflects
our strong commitment to the Quebec market, where we have two production
facilities, as well as access to significant additional supply
through our partnership with The Green Organic Dutchman, once their
Valleyfield facility is completed.
We are pleased to be working closely with the SAQ, and look forward
to becoming a key supplier of Canada's second most populous province with
more than eight million people."
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
("ACMPR"). The Company operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County,
Alberta, known as "Aurora
Mountain", and a second 40,000 square foot high-technology
production facility known as "Aurora Vie" in Pointe-Claire, Quebec on Montreal's West Island. Aurora is also
currently constructing an 800,000 square foot production facility,
known as "Aurora Sky", at the Edmonton International Airport, as well as
completing a fourth facility in Lachute,
Quebec utilizing its wholly owned subsidiary Aurora Larssen
Projects Ltd.
Aurora also owns Berlin-based
Pedanios, the leading wholesale importer, exporter, and distributor
of medical cannabis in the European Union. The Company offers
further differentiation through its acquisition of BC Northern
Lights Ltd. and Urban Cultivator Inc., industry leaders,
respectively, in the production and sale of proprietary systems for
the safe, efficient and high-yield indoor cultivation of cannabis,
and in state-of-the-art indoor gardening appliances for the
cultivation of organic microgreens, vegetables and herbs in home
and professional kitchens.
In addition, the Company holds approximately 17.23% of the
issued shares in leading extraction technology company Radient
Technologies Inc., and has a strategic investment in Hempco Food
and Fiber Inc., with options to increase ownership stake to over
50%. Aurora is also the cornerstone investor in two other licensed
producers, with a 22.9% stake in Cann Group Limited, the first
Australian company licensed to conduct research on and cultivate
medical cannabis, and a 17.62% stake in Canadian producer The Green
Organic Dutchman Ltd., with options to increase to majority
ownership.
Aurora's common shares trade on the TSX under the symbol
"ACB".
On behalf of the Boards of
Directors,
AURORA CANNABIS
INC.
Terry
Booth
CEO
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"), including, but not
limited to, statements with respect to the performance of the
Company. Forward-looking statements are frequently characterized by
words such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. These statements are
only predictions. Various assumptions were used in drawing the
conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made, and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward-looking statements. The Company is
under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as expressly required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accept
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.